MDCM
GILD icon

Morgan Dempsey Capital Management’s Gilead Sciences GILD Stock Holding History

Morgan Dempsey Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-350
Closed -$38.9K – 154
2025
Q3 		$38.9K Hold
350
– – 0.02% 92
2025
Q2 		$38.8K Hold
350
– – 0.02% 90
2025
Q1 		$39.2K Hold
350
– – 0.02% 76
2024
Q4 		$32.3K Sell
350
-85,286
-100% -$7.68M 0.01% 75
2024
Q3 		$7.18M Sell
85,636
-43,409
-34% -$3.31M 2.46% 25
2024
Q2 		$8.85M Sell
129,045
-5,165
-4% -$345K 2.95% 14
2024
Q1 		$9.83M Sell
134,210
-16,637
-11% -$1.28M 3.14% 7
2023
Q4 		$12.2M Sell
150,847
-8,676
-5% -$675K 3.74% 1
2023
Q3 		$12M Sell
159,523
-4,496
-3% -$346K 3.72% 3
2023
Q2 		$12.6M Sell
164,019
-2,633
-2% -$210K 3.61% 4
2023
Q1 		$13.8M Buy
166,652
+3,538
+2% +$293K 3.74% 2
2022
Q4 		$14M Buy
163,114
+5,405
+3% +$428K 3.88% 2
2022
Q3 		$9.73M Buy
157,709
+1,554
+1% +$98K 3.2% 5
2022
Q2 		$9.65M Buy
156,155
+26,721
+21% +$1.65M 2.94% 10
2022
Q1 		$7.7M Sell
129,434
-1,728
-1% -$110K 2.28% 29
2021
Q4 		$9.52M Sell
131,162
-4,759
-4% -$328K 2.96% 12
2021
Q3 		$9.49M Sell
135,921
-6,712
-5% -$472K 3.12% 7
2021
Q2 		$9.82M Buy
142,633
+24,218
+20% +$1.62M 3.08% 8
2021
Q1 		$7.65M Buy
118,415
+21,906
+23% +$1.41M 2.42% 29
2020
Q4 		$5.62M Sell
96,509
-22,883
-19% -$1.38M 2.29% 29
2020
Q3 		$7.54M Buy
119,392
+5,881
+5% +$408K 2.89% 18
2020
Q2 		$8.73M Buy
113,511
+7,160
+7% +$549K 3.57% 6
2020
Q1 		$7.95M Buy
106,351
+5,554
+6% +$384K 3.85% 4
2019
Q4 		$6.55M Buy
100,797
+54,426
+117% +$3.54M 2.61% 21
2019
Q3 		$2.94M Buy
46,371
+2,494
+6% +$163K 1.08% 35
2019
Q2 		$2.96M Buy
43,877
+3,155
+8% +$208K 1.11% 36
2019
Q1 		$2.65M Buy
+40,722
New +$2.71M 1.05% 39

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Morgan Dempsey Capital Management's GILD Position: Q4 2025 in Review

Morgan Dempsey Capital Management sold out of Gilead Sciences (GILD) in Q4 2025, closing a stake of 350 shares — an estimated $38.9K sold.

Morgan Dempsey Capital Management first reported a position in GILD in Q1 2019 and held it in 27 quarters. The position peaked at $14M in Q4 2022. 2,225 funds tracked by Wall St. Rank hold GILD as of Q4 2025.

  • Morgan Dempsey Capital Management reported no remaining Gilead Sciences position as of Q4 2025 after selling out during the quarter.
  • Morgan Dempsey Capital Management sold 350 Gilead Sciences shares in Q4 2025, an estimated $38.9K.
  • Morgan Dempsey Capital Management first reported a position in Gilead Sciences in Q1 2019 and held it in 27 quarters.
  • Morgan Dempsey Capital Management's Gilead Sciences position peaked at $14M in Q4 2022.
  • 2,225 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2025.

Based on Morgan Dempsey Capital Management's 13F filing for Q4 2025, filed 13 Feb 2026.